{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:14:43Z","timestamp":1787163283253,"version":"build-2736575974"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,18]]},"DOI":"10.7759\/cureus.64873","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T01:00:55Z","timestamp":1721350855000},"source":"Crossref","is-referenced-by-count":4,"title":["Ethambutol-Induced Optic Neuritis and Vision Loss: A Case Report"],"prefix":"10.7759","author":[{"given":"Jaykumar","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetna","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paras","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajal","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh","family":"Sojitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Standard Treatment Workflow (STW) Guidelines for Drug Sensitive-TB Treatment as Per NTEP. (2022). Accessed. July 2024: https:\/\/main.icmr.nic.in\/sites\/default\/files\/STWsDownload\/Investigations_Treatment\/2_NTEP_18032022.pdf."},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.4103\/2320-8775.196644","article-title":"Recent changes in technical and operational guidelines for tuberculosis control programme in India - 2016: A paradigm shift in tuberculosis control","volume":"5","author":"Chaudhuri A","year":"2017","unstructured":"Chaudhuri A. Recent changes in technical and operational guidelines for tuberculosis control programme in India - 2016: A paradigm shift in tuberculosis control. J Assoc Chest Physicians. 2017, 5:1.","journal-title":"J Assoc Chest Physicians"},{"key":"ref3","article-title":"Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 14th Edition","author":"Brunton LL","year":"2023","unstructured":"Brunton LL, Knollmann BC. Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 14th Edition. Weitz M, Thomas CM (ed): McGraw-Hill, New York; 2023."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i2.663","article-title":"Ethambutol-induced optic neuropathy with rare bilateral asymmetry onset: a case report","volume":"10","author":"Sheng WY","year":"2022","unstructured":"Sheng WY, Wu SQ, Su LY, Zhu LW. Ethambutol-induced optic neuropathy with rare bilateral asymmetry onset: a case report. World J Clin Cases. 2022, 10:663-70. 10.12998\/wjcc.v10.i2.663","journal-title":"World J Clin Cases"},{"key":"ref5","unstructured":"The use of the WHO-UMC system for standardised case causality assessment. (2023). Accessed. July 2024: https:\/\/cdn.who.int\/media\/docs\/default-source\/medicines\/pharmacovigilance\/whocausality-assessment.pdf?sfvrsn=5d8130bb...."},{"key":"ref6","article-title":"Focusing on the preventability of adverse drug reactions","volume":"27","author":"Schumock GT","year":"1992","unstructured":"Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992, 27:538.","journal-title":"Hosp Pharm"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/0970-2113.148395","article-title":"Ocular toxicity with ethambutol therapy: Timely recaution","volume":"32","author":"Koul PA","year":"2015","unstructured":"Koul PA. Ocular toxicity with ethambutol therapy: Timely recaution. Lung India. 2015, 32:1-3. 10.4103\/0970-2113.148395","journal-title":"Lung India"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-022-03227-9","article-title":"Exploration of the plausible mechanism of ethambutol induced ocular toxicity by using proteomics informed physiologically based pharmacokinetic (PBPK) modeling","volume":"39","author":"Balhara A","year":"2022","unstructured":"Balhara A, Ladumor MK, Nankar RP, Syed SD, Giri S, Prasad B, Singh S. Exploration of the plausible mechanism of ethambutol induced ocular toxicity by using proteomics informed physiologically based pharmacokinetic (PBPK) modeling. Pharm Res. 2022, 39:677-89. 10.1007\/s11095-022-03227-9","journal-title":"Pharm Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12515","article-title":"Toxic optic neuropathies: an updated review","volume":"93","author":"Grzybowski A","year":"2015","unstructured":"Grzybowski A, Z\u00fclsdorff M, Wilhelm H, Tonagel F. Toxic optic neuropathies: an updated review. Acta Ophthalmol. 2015, 93:402-10. 10.1111\/aos.12515","journal-title":"Acta Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/269603-ethambutol-induced-optic-neuritis-and-vision-loss-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T01:01:00Z","timestamp":1721350860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/269603-ethambutol-induced-optic-neuritis-and-vision-loss-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.64873","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,18]]}}}